Akèy › Hypertension artérielle
Etid klinik pou Hypertension artérielle ap rekrite nan Etazini
188 etid pou Hypertension artérielle ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Chicago, IL22 etid
- Boston, MA21 etid
- Dallas, TX16 etid
- Nashville, TN14 etid
- Houston, TX11 etid
- Tucson, AZ10 etid
- Birmingham, AL10 etid
- Durham, NC10 etid
- Atlanta, GA10 etid
- Washington, DC9 etid
- Baltimore, MD9 etid
- New York City, NY9 etid
- Philadelphia, PA9 etid
- Miami, FL9 etid
- Charlotte, NC9 etid
- Arlington, VA8 etid
- Wichita, KS8 etid
- Cincinnati, OH8 etid
- Pittsburgh, PA8 etid
- Cleveland, OH8 etid
- Rochester, MN8 etid
- Detroit, MI8 etid
- Orlando, FL8 etid
- Las Vegas, NV7 etid
- Salt Lake City, UT7 etid
- San Antonio, TX7 etid
- Winston-Salem, NC7 etid
- Los Angeles, CA7 etid
- Austin, TX7 etid
- Richmond, VA7 etid
- Tampa, FL6 etid
- Mountain View, CA6 etid
- Harrisburg, PA6 etid
- New Orleans, LA6 etid
- Indianapolis, IN6 etid
- Charleston, SC5 etid
- Cicero, IL5 etid
- St. Louis, MO5 etid
- Concord, CA5 etid
- Memphis, TN5 etid
Pa eta
- Alabama15 etid
- Arizona13 etid
- Ayiti3 etid
- Colorado13 etid
- Connecticut10 etid
- Distrik Columbia3 etid
- Florid22 etid
- Georgia21 etid
- Idaho4 etid
- Illinois29 etid
- Indiana9 etid
- Iowa4 etid
- Kalifòni28 etid
- Kansas11 etid
- Kentucky6 etid
- Lwizyàn11 etid
- Maryland18 etid
- Massachusetts26 etid
- Michigan19 etid
- Minnesota16 etid
- Mississippi6 etid
- Missouri11 etid
- Nebraska5 etid
- Nevada9 etid
- New Jersey9 etid
- New Mexico4 etid
- New York14 etid
- North Carolina23 etid
- North Dakota3 etid
- Ohio18 etid
- Oklahoma8 etid
- Oregon3 etid
- Pennsylvania18 etid
- South Carolina14 etid
- Tennessee20 etid
- Texas27 etid
- Utah8 etid
- Virginia13 etid
- Washington4 etid
- West Virginia4 etid
- Wisconsin4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Ap rekrite
Laj 18 a 85 · Tout sèks · Mizajou Oct 1, 2026 · NCT07214376AM vs PM Exercise Training
Ap rekrite
Laj 55 a 80 · Fanm · Mizajou Oct 1, 2026 · NCT06042439Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06133322Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07511361EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07783802Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT06948838Autonomic and Renal Contributions to Hypertension With ADT
Ap rekriteFaz 4Volontè an sante akeyi
Laj 40 ak plis · Gason · Mizajou Sep 30, 2026 · NCT07848828Diabetes and Heart Disease Risk in Blacks
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Sep 28, 2026 · NCT00001853A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07794579Obstructive Sleep Apnea Among Somali-Americans
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT04124848A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06742723: Vascular Function in Health and Disease
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT02966665Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension
Ap rekriteFaz 1 bonè
Laj 18 a 65 · Tout sèks · Mizajou Sep 24, 2026 · NCT06482853BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06059638THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
Ap rekrite
Laj 22 a 75 · Tout sèks · Mizajou Sep 24, 2026 · NCT06559891Treatment With Aspirin After Preeclampsia: TAP Trial
Ap rekriteFaz 4
Laj 18 a 55 · Fanm · Mizajou Sep 22, 2026 · NCT06281665Lifestyle Intervention In CKD
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07633145Improving the Collaborative Health of Adult Dyads
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05370014Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 7 a 70 · Tout sèks · Mizajou Sep 16, 2026 · NCT03374215A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 14, 2026 · NCT07553442OBPM_PANDA2026: Evaluation of the Performance and Safety of the Aktiia Periodic Optical Blood Pressure Monitoring Device
Ap rekriteVolontè an sante akeyi
Laj 22 a 59 · Tout sèks · Mizajou Sep 14, 2026 · NCT07507903Study of Disrupted Sleep in Somali Americans
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Sep 14, 2026 · NCT05411029A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06150560Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.